1206970-19-5

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-aminocyclobutanecarboxylate is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs with diverse therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 3-aminocyclobutanecarboxylate is utilized as a building block for the creation of agrochemicals, such as pesticides and herbicides, due to its reactivity and potential to form biologically active compounds.
Used as an Enzyme Inhibitor:
Methyl 3-aminocyclobutanecarboxylate is used as an inhibitor for enzymes like acetylcholinesterase, which plays a significant role in the treatment of neurological diseases by modulating the levels of acetylcholine in the synaptic cleft, thereby influencing neurotransmission.
Used in Organic Synthesis:
As a versatile chemical compound, Methyl 3-aminocyclobutanecarboxylate is employed in organic synthesis for the preparation of a wide range of organic compounds, including those with potential applications in materials science, chemical research, and the development of new chemical entities.

Upstream product

• 1101173-77-6 methyl 3-((tert-butoxycarbonyl)amino)cyclobutanecarboxylate 
• 67-56-1 methanol 
• 1101173-77-6 (1s,3s)-methyl 3-((tert-butoxycarbonyl)amino)cyclobutane-carboxylate 
• 15963-46-9 3-chlorocyclobutanecarboxylic acid methyl ester 
• 89639-43-0 3-chlorocyclobutane-1,1-dicarboxylic acid 
• 30494-32-7 3-chlorocyclobutane carboxylic acid chloride 
• 5445-51-2 cyclobutane-1,1'-dicarboxylic acid 
• 35207-71-7 3-chlorocyclobutane-1-carboxylic acid 
• 79584-22-8 cis-methyl 3-azidocyclobutanecarboxylate 
• 79584-09-1 trans-methyl 3-azidocyclobutanecarboxylate 

Downstream Products

• 74307-75-8 (1r,3r)-3-aminocyclobutane-1-carboxylic acid 
• 74316-27-1 cis-3-aminocyclobutane-1-carboxylic acid 

Relevant academic research and scientific papers

SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS

The application relates to a compound of Formula (I') or (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I') or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.

Fragment-Linking Approach Using 19F NMR Spectroscopy to Obtain Highly Potent and Selective Inhibitors of β-Secretase

Fragment-based drug discovery (FBDD) has become a widely used tool in small-molecule drug discovery efforts. One of the most commonly used biophysical methods in detecting weak binding of fragments is nuclear magnetic resonance (NMR) spectroscopy. In part

SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.

Expedient synthesis of cis- and trans-3-aminocyclobutanecarboxylic acids

An expedient approach to cis- and trans-3-aminocyclobutanecarboxylic acids was developed starting from 1,1-cyclobutanedicarboxylic acid. Stereochemistry of the title compounds was established by nuclear Overhauser effect spectroscopy experiments.